The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

Eli Lilly's next Phase III trial is assessing whether lepodisiran can not only reduce levels of lipoprotein(a) but also ...